Related Experiment Video
Updated: Dec 6, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.3K
[Advances in flavoring-related bronchiolitis obliterans]
1Department of Occupational Medicine and Toxicology, Clinical Center for Interstitial Lung Diseases, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Summary
Workers exposed to diacetyl flavoring can develop bronchiolitis obliterans (BO). This review covers disease recognition, risk factors, and pathogenesis to improve awareness and prevention, especially in China where no cases are reported.
Area of Science:
- Occupational Health
- Pulmonary Medicine
- Toxicology
Background:
- Occupational exposure to diacetyl flavoring is linked to bronchiolitis obliterans (BO).
- The first case was reported in 2002, with subsequent cases identified globally.
- No cases have been reported in China to date.
Purpose of the Study:
- To review research progress on diacetyl-induced bronchiolitis obliterans.
- To enhance awareness and promote prevention strategies.
- To summarize current knowledge on case recognition, risk factors, clinical manifestations, and pathogenesis.
Main Methods:
- Literature review of scientific articles and case reports.
- Synthesis of information on diacetyl exposure and respiratory disease.
- Analysis of epidemiological data and clinical findings.
Main Results:
- Diacetyl flavoring is a recognized occupational hazard.
- Bronchiol অবস্থা obliterans presents with distinct clinical features.
- Various industrial settings have reported cases, highlighting widespread risk.
Conclusions:
- Increased awareness of diacetyl-related BO is crucial for worker protection.
- Further research is needed to fully understand pathogenesis and refine prevention.
- Implementing targeted surveillance and control measures is essential, particularly in regions without reported cases.
Related Concept Videos
01:29Acute Respiratory Failure-V
332
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
332
01:26COPD: Management Using Bronchodilators and Corticosteroids
598
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
598
01:20COPD: Pathogenesis and Clinical Features
1.6K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
01:30Asthma-IV: Diagnostic and Management
2.9K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K
01:20Asthma: Pathogenesis and Management
1.0K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
01:30Asthma-IV: Nursing Management
3.5K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.5K